nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyclothiazide—Vasculitis—Lovastatin—atherosclerosis	0.0168	0.0168	CcSEcCtD
Methyclothiazide—Vasculitis—Ezetimibe—atherosclerosis	0.0165	0.0165	CcSEcCtD
Methyclothiazide—Vasculitis—Simvastatin—atherosclerosis	0.0157	0.0157	CcSEcCtD
Methyclothiazide—Hyperuricaemia—Niacin—atherosclerosis	0.0152	0.0152	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Niacin—atherosclerosis	0.0144	0.0144	CcSEcCtD
Methyclothiazide—Vasculitis—Pravastatin—atherosclerosis	0.0142	0.0142	CcSEcCtD
Methyclothiazide—Photosensitivity—Lovastatin—atherosclerosis	0.0136	0.0136	CcSEcCtD
Methyclothiazide—Vascular purpura—Lovastatin—atherosclerosis	0.0133	0.0133	CcSEcCtD
Methyclothiazide—Photosensitivity—Ezetimibe—atherosclerosis	0.0133	0.0133	CcSEcCtD
Methyclothiazide—Haemolytic anaemia—Lovastatin—atherosclerosis	0.0132	0.0132	CcSEcCtD
Methyclothiazide—Photosensitivity—Simvastatin—atherosclerosis	0.0127	0.0127	CcSEcCtD
Methyclothiazide—Vascular purpura—Simvastatin—atherosclerosis	0.0125	0.0125	CcSEcCtD
Methyclothiazide—Purpura—Lovastatin—atherosclerosis	0.0124	0.0124	CcSEcCtD
Methyclothiazide—Haemolytic anaemia—Simvastatin—atherosclerosis	0.0123	0.0123	CcSEcCtD
Methyclothiazide—Pancreatitis—Rosuvastatin—atherosclerosis	0.0119	0.0119	CcSEcCtD
Methyclothiazide—Purpura—Simvastatin—atherosclerosis	0.0116	0.0116	CcSEcCtD
Methyclothiazide—Photosensitivity—Pravastatin—atherosclerosis	0.0115	0.0115	CcSEcCtD
Methyclothiazide—Vascular purpura—Pravastatin—atherosclerosis	0.0113	0.0113	CcSEcCtD
Methyclothiazide—Haemolytic anaemia—Pravastatin—atherosclerosis	0.0112	0.0112	CcSEcCtD
Methyclothiazide—Cramp muscle—Lovastatin—atherosclerosis	0.0107	0.0107	CcSEcCtD
Methyclothiazide—Jaundice—Rosuvastatin—atherosclerosis	0.0106	0.0106	CcSEcCtD
Methyclothiazide—Cramp muscle—Ezetimibe—atherosclerosis	0.0105	0.0105	CcSEcCtD
Methyclothiazide—Purpura—Pravastatin—atherosclerosis	0.0105	0.0105	CcSEcCtD
Methyclothiazide—Pancreatitis—Lovastatin—atherosclerosis	0.0101	0.0101	CcSEcCtD
Methyclothiazide—Cramp muscle—Simvastatin—atherosclerosis	0.01	0.01	CcSEcCtD
Methyclothiazide—Pancreatitis—Ezetimibe—atherosclerosis	0.0099	0.0099	CcSEcCtD
Methyclothiazide—Pancreatitis—Simvastatin—atherosclerosis	0.00944	0.00944	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Lovastatin—atherosclerosis	0.0094	0.0094	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Niacin—atherosclerosis	0.00934	0.00934	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.00922	0.00922	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.0091	0.0091	CcSEcCtD
Methyclothiazide—Cramp muscle—Pravastatin—atherosclerosis	0.00907	0.00907	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Simvastatin—atherosclerosis	0.00879	0.00879	CcSEcCtD
Methyclothiazide—Jaundice—Ezetimibe—atherosclerosis	0.00878	0.00878	CcSEcCtD
Methyclothiazide—Pancreatitis—Pravastatin—atherosclerosis	0.00854	0.00854	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00851	0.00851	CcSEcCtD
Methyclothiazide—Jaundice—Simvastatin—atherosclerosis	0.00837	0.00837	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Pravastatin—atherosclerosis	0.00795	0.00795	CcSEcCtD
Methyclothiazide—Erythema multiforme—Lovastatin—atherosclerosis	0.00779	0.00779	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.0077	0.0077	CcSEcCtD
Methyclothiazide—Jaundice—Niacin—atherosclerosis	0.00768	0.00768	CcSEcCtD
Methyclothiazide—Erythema multiforme—Ezetimibe—atherosclerosis	0.00764	0.00764	CcSEcCtD
Methyclothiazide—Jaundice—Pravastatin—atherosclerosis	0.00757	0.00757	CcSEcCtD
Methyclothiazide—Erythema multiforme—Simvastatin—atherosclerosis	0.00729	0.00729	CcSEcCtD
Methyclothiazide—Malnutrition—Ezetimibe—atherosclerosis	0.00704	0.00704	CcSEcCtD
Methyclothiazide—Muscle spasms—Lovastatin—atherosclerosis	0.0069	0.0069	CcSEcCtD
Methyclothiazide—Muscle spasms—Ezetimibe—atherosclerosis	0.00676	0.00676	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00676	0.00676	CcSEcCtD
Methyclothiazide—Vision blurred—Lovastatin—atherosclerosis	0.00676	0.00676	CcSEcCtD
Methyclothiazide—Erythema multiforme—Pravastatin—atherosclerosis	0.00659	0.00659	CcSEcCtD
Methyclothiazide—Muscle spasms—Simvastatin—atherosclerosis	0.00645	0.00645	CcSEcCtD
Methyclothiazide—Vertigo—Lovastatin—atherosclerosis	0.00644	0.00644	CcSEcCtD
Methyclothiazide—Leukopenia—Lovastatin—atherosclerosis	0.00642	0.00642	CcSEcCtD
Methyclothiazide—Vision blurred—Simvastatin—atherosclerosis	0.00632	0.00632	CcSEcCtD
Methyclothiazide—Paraesthesia—Rosuvastatin—atherosclerosis	0.0062	0.0062	CcSEcCtD
Methyclothiazide—Malnutrition—Niacin—atherosclerosis	0.00616	0.00616	CcSEcCtD
Methyclothiazide—Vertigo—Simvastatin—atherosclerosis	0.00603	0.00603	CcSEcCtD
Methyclothiazide—Leukopenia—Simvastatin—atherosclerosis	0.00601	0.00601	CcSEcCtD
Methyclothiazide—Muscle spasms—Niacin—atherosclerosis	0.00592	0.00592	CcSEcCtD
Methyclothiazide—Constipation—Rosuvastatin—atherosclerosis	0.00591	0.00591	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Lovastatin—atherosclerosis	0.00585	0.00585	CcSEcCtD
Methyclothiazide—Muscle spasms—Pravastatin—atherosclerosis	0.00583	0.00583	CcSEcCtD
Methyclothiazide—Vision blurred—Niacin—atherosclerosis	0.00581	0.00581	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00574	0.00574	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Lovastatin—atherosclerosis	0.00573	0.00573	CcSEcCtD
Methyclothiazide—Vision blurred—Pravastatin—atherosclerosis	0.00572	0.00572	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00562	0.00562	CcSEcCtD
Methyclothiazide—Anorexia—Lovastatin—atherosclerosis	0.00558	0.00558	CcSEcCtD
Methyclothiazide—Vertigo—Niacin—atherosclerosis	0.00554	0.00554	CcSEcCtD
Methyclothiazide—Leukopenia—Niacin—atherosclerosis	0.00551	0.00551	CcSEcCtD
Methyclothiazide—Urticaria—Rosuvastatin—atherosclerosis	0.00549	0.00549	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Simvastatin—atherosclerosis	0.00548	0.00548	CcSEcCtD
Methyclothiazide—Vertigo—Pravastatin—atherosclerosis	0.00545	0.00545	CcSEcCtD
Methyclothiazide—Leukopenia—Pravastatin—atherosclerosis	0.00543	0.00543	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Simvastatin—atherosclerosis	0.00536	0.00536	CcSEcCtD
Methyclothiazide—Paraesthesia—Lovastatin—atherosclerosis	0.00526	0.00526	CcSEcCtD
Methyclothiazide—Anorexia—Simvastatin—atherosclerosis	0.00522	0.00522	CcSEcCtD
Methyclothiazide—Paraesthesia—Ezetimibe—atherosclerosis	0.00516	0.00516	CcSEcCtD
Methyclothiazide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00509	0.00509	CcSEcCtD
Methyclothiazide—Decreased appetite—Lovastatin—atherosclerosis	0.00509	0.00509	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Niacin—atherosclerosis	0.00503	0.00503	CcSEcCtD
Methyclothiazide—Constipation—Lovastatin—atherosclerosis	0.00501	0.00501	CcSEcCtD
Methyclothiazide—Decreased appetite—Ezetimibe—atherosclerosis	0.00499	0.00499	CcSEcCtD
Methyclothiazide—Asthenia—Rosuvastatin—atherosclerosis	0.00496	0.00496	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Pravastatin—atherosclerosis	0.00495	0.00495	CcSEcCtD
Methyclothiazide—Paraesthesia—Simvastatin—atherosclerosis	0.00492	0.00492	CcSEcCtD
Methyclothiazide—Constipation—Ezetimibe—atherosclerosis	0.00491	0.00491	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Pravastatin—atherosclerosis	0.00485	0.00485	CcSEcCtD
Methyclothiazide—Anorexia—Niacin—atherosclerosis	0.00479	0.00479	CcSEcCtD
Methyclothiazide—Decreased appetite—Simvastatin—atherosclerosis	0.00476	0.00476	CcSEcCtD
Methyclothiazide—Diarrhoea—Rosuvastatin—atherosclerosis	0.00473	0.00473	CcSEcCtD
Methyclothiazide—Anorexia—Pravastatin—atherosclerosis	0.00472	0.00472	CcSEcCtD
Methyclothiazide—Constipation—Simvastatin—atherosclerosis	0.00468	0.00468	CcSEcCtD
Methyclothiazide—Urticaria—Lovastatin—atherosclerosis	0.00465	0.00465	CcSEcCtD
Methyclothiazide—Body temperature increased—Lovastatin—atherosclerosis	0.00463	0.00463	CcSEcCtD
Methyclothiazide—Dizziness—Rosuvastatin—atherosclerosis	0.00457	0.00457	CcSEcCtD
Methyclothiazide—Urticaria—Ezetimibe—atherosclerosis	0.00456	0.00456	CcSEcCtD
Methyclothiazide—Body temperature increased—Ezetimibe—atherosclerosis	0.00454	0.00454	CcSEcCtD
Methyclothiazide—Paraesthesia—Niacin—atherosclerosis	0.00451	0.00451	CcSEcCtD
Methyclothiazide—Paraesthesia—Pravastatin—atherosclerosis	0.00445	0.00445	CcSEcCtD
Methyclothiazide—Decreased appetite—Niacin—atherosclerosis	0.00437	0.00437	CcSEcCtD
Methyclothiazide—Rash—Rosuvastatin—atherosclerosis	0.00436	0.00436	CcSEcCtD
Methyclothiazide—Dermatitis—Rosuvastatin—atherosclerosis	0.00435	0.00435	CcSEcCtD
Methyclothiazide—Urticaria—Simvastatin—atherosclerosis	0.00435	0.00435	CcSEcCtD
Methyclothiazide—Body temperature increased—Simvastatin—atherosclerosis	0.00433	0.00433	CcSEcCtD
Methyclothiazide—Headache—Rosuvastatin—atherosclerosis	0.00433	0.00433	CcSEcCtD
Methyclothiazide—Hypersensitivity—Lovastatin—atherosclerosis	0.00431	0.00431	CcSEcCtD
Methyclothiazide—Decreased appetite—Pravastatin—atherosclerosis	0.0043	0.0043	CcSEcCtD
Methyclothiazide—Constipation—Pravastatin—atherosclerosis	0.00423	0.00423	CcSEcCtD
Methyclothiazide—Hypersensitivity—Ezetimibe—atherosclerosis	0.00423	0.00423	CcSEcCtD
Methyclothiazide—Asthenia—Lovastatin—atherosclerosis	0.0042	0.0042	CcSEcCtD
Methyclothiazide—Asthenia—Ezetimibe—atherosclerosis	0.00412	0.00412	CcSEcCtD
Methyclothiazide—Nausea—Rosuvastatin—atherosclerosis	0.0041	0.0041	CcSEcCtD
Methyclothiazide—Hypersensitivity—Simvastatin—atherosclerosis	0.00403	0.00403	CcSEcCtD
Methyclothiazide—Diarrhoea—Lovastatin—atherosclerosis	0.00401	0.00401	CcSEcCtD
Methyclothiazide—Urticaria—Niacin—atherosclerosis	0.00399	0.00399	CcSEcCtD
Methyclothiazide—Body temperature increased—Niacin—atherosclerosis	0.00397	0.00397	CcSEcCtD
Methyclothiazide—Urticaria—Pravastatin—atherosclerosis	0.00393	0.00393	CcSEcCtD
Methyclothiazide—Asthenia—Simvastatin—atherosclerosis	0.00393	0.00393	CcSEcCtD
Methyclothiazide—Diarrhoea—Ezetimibe—atherosclerosis	0.00393	0.00393	CcSEcCtD
Methyclothiazide—Body temperature increased—Pravastatin—atherosclerosis	0.00391	0.00391	CcSEcCtD
Methyclothiazide—Dizziness—Lovastatin—atherosclerosis	0.00387	0.00387	CcSEcCtD
Methyclothiazide—Dizziness—Ezetimibe—atherosclerosis	0.0038	0.0038	CcSEcCtD
Methyclothiazide—Diarrhoea—Simvastatin—atherosclerosis	0.00375	0.00375	CcSEcCtD
Methyclothiazide—Vomiting—Lovastatin—atherosclerosis	0.00372	0.00372	CcSEcCtD
Methyclothiazide—Hypersensitivity—Niacin—atherosclerosis	0.0037	0.0037	CcSEcCtD
Methyclothiazide—Rash—Lovastatin—atherosclerosis	0.00369	0.00369	CcSEcCtD
Methyclothiazide—Dermatitis—Lovastatin—atherosclerosis	0.00369	0.00369	CcSEcCtD
Methyclothiazide—Headache—Lovastatin—atherosclerosis	0.00367	0.00367	CcSEcCtD
Methyclothiazide—Vomiting—Ezetimibe—atherosclerosis	0.00365	0.00365	CcSEcCtD
Methyclothiazide—Hypersensitivity—Pravastatin—atherosclerosis	0.00365	0.00365	CcSEcCtD
Methyclothiazide—Dizziness—Simvastatin—atherosclerosis	0.00362	0.00362	CcSEcCtD
Methyclothiazide—Rash—Ezetimibe—atherosclerosis	0.00362	0.00362	CcSEcCtD
Methyclothiazide—Dermatitis—Ezetimibe—atherosclerosis	0.00362	0.00362	CcSEcCtD
Methyclothiazide—Asthenia—Niacin—atherosclerosis	0.00361	0.00361	CcSEcCtD
Methyclothiazide—Headache—Ezetimibe—atherosclerosis	0.0036	0.0036	CcSEcCtD
Methyclothiazide—Asthenia—Pravastatin—atherosclerosis	0.00355	0.00355	CcSEcCtD
Methyclothiazide—Vomiting—Simvastatin—atherosclerosis	0.00348	0.00348	CcSEcCtD
Methyclothiazide—Nausea—Lovastatin—atherosclerosis	0.00348	0.00348	CcSEcCtD
Methyclothiazide—Rash—Simvastatin—atherosclerosis	0.00345	0.00345	CcSEcCtD
Methyclothiazide—Dermatitis—Simvastatin—atherosclerosis	0.00345	0.00345	CcSEcCtD
Methyclothiazide—Diarrhoea—Niacin—atherosclerosis	0.00344	0.00344	CcSEcCtD
Methyclothiazide—Headache—Simvastatin—atherosclerosis	0.00343	0.00343	CcSEcCtD
Methyclothiazide—Nausea—Ezetimibe—atherosclerosis	0.00341	0.00341	CcSEcCtD
Methyclothiazide—Diarrhoea—Pravastatin—atherosclerosis	0.00339	0.00339	CcSEcCtD
Methyclothiazide—Dizziness—Niacin—atherosclerosis	0.00332	0.00332	CcSEcCtD
Methyclothiazide—Dizziness—Pravastatin—atherosclerosis	0.00327	0.00327	CcSEcCtD
Methyclothiazide—Nausea—Simvastatin—atherosclerosis	0.00325	0.00325	CcSEcCtD
Methyclothiazide—Vomiting—Niacin—atherosclerosis	0.0032	0.0032	CcSEcCtD
Methyclothiazide—Rash—Niacin—atherosclerosis	0.00317	0.00317	CcSEcCtD
Methyclothiazide—Dermatitis—Niacin—atherosclerosis	0.00317	0.00317	CcSEcCtD
Methyclothiazide—Headache—Niacin—atherosclerosis	0.00315	0.00315	CcSEcCtD
Methyclothiazide—Vomiting—Pravastatin—atherosclerosis	0.00315	0.00315	CcSEcCtD
Methyclothiazide—Rash—Pravastatin—atherosclerosis	0.00312	0.00312	CcSEcCtD
Methyclothiazide—Dermatitis—Pravastatin—atherosclerosis	0.00312	0.00312	CcSEcCtD
Methyclothiazide—Headache—Pravastatin—atherosclerosis	0.0031	0.0031	CcSEcCtD
Methyclothiazide—Nausea—Niacin—atherosclerosis	0.00299	0.00299	CcSEcCtD
Methyclothiazide—Nausea—Pravastatin—atherosclerosis	0.00294	0.00294	CcSEcCtD
